Petco Health and Wellness Company, Inc. filings document the formal disclosures of a pet specialty retailer with Class A common stock listed on Nasdaq under WOOF. Its Form 8-K reports cover operating results, earnings presentations, Regulation FD updates, fiscal outlooks and material events tied to the company's retail, services and digital pet-care business.
Petco's regulatory record also includes capital-structure disclosures for credit agreement amendments, term loan refinancing, senior secured notes due 2031, subsidiary guarantees and collateral priorities. Governance filings document board leadership changes and related compensatory arrangements, while exhibit filings preserve press releases, agreements and other materials incorporated into the company's public record.
Petco Health & Wellness Company, Inc. Chief Legal Officer and Secretary Giovanni Insana had 22,308 shares withheld to satisfy his tax liability when a portion of his RSUs vested on October 15, 2026. The reported transaction price was $2.37 per share. His reported post-transaction position was 364,351 shares, including 127,960 outstanding RSUs. No Rule 10b5-1 plan is reported.
Petco Health & Wellness Company, Inc. (symbol: WOOF) is the issuer of record for a Form 4 filing submitted to the SEC. Anderson Joel D reported disposition transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. CEO Joel D. Anderson reported that the Revocable Trust contributed 705,000 Class A common shares to the 2020 Trust on September 22, 2026. In exchange, the Revocable Trust withdrew an amount equal to $2.37 per share from the 2020 Trust. Anderson believes the contribution constitutes a change in the form of beneficial ownership exempted by Rule 16a-13. As of September 22, 2026, reported holdings were 87,233 shares through the Revocable Trust, 3,134,235 through the 2020 Trust, 229,204 through the 2025 Trust and 1,361,684 direct shares, including 1,347,723 outstanding RSUs.
Petco Health & Wellness Company, Inc. (WOOF) reported that Chief Revenue Officer Patrick J. Venezia had 14,948 shares of Class A common stock withheld on September 4, 2026 to satisfy tax liability arising from vesting restricted stock units granted under the 2021 Equity Incentive Plan, at a reference value of $2.52 per share. After this tax-withholding disposition, he holds 357,764 shares directly, including 299,125 outstanding RSUs, and no Rule 10b5-1 trading plan is reported.
Petco Health & Wellness Company, Inc. (WOOF) reported that Chief Financial Officer Sabrina Simmons had 119,445 shares of Class A common stock withheld on September 4, 2026 to pay tax liabilities arising from vesting restricted stock units (RSUs), in two code F transactions at $2.52 per share. These RSUs were granted on March 4, 2025 under the company’s 2021 Equity Incentive Plan, and a portion vested on September 4, 2026; no Rule 10b5-1 trading plan is reported.
Petco Health & Wellness Company, Inc. (WOOF) reported that Chief Customer and Product Officer Michael Romanko had 90,138 shares of Class A common stock withheld on September 4, 2026 to satisfy tax liability related to vesting restricted stock units (RSUs) granted under the company’s 2021 Equity Incentive Plan. After this tax-withholding disposition, he directly holds 1,100,807 shares of Class A common stock, including 653,965 outstanding RSUs, each representing the right to receive one share upon settlement. No Rule 10b5-1 trading plan is reported for this transaction.
Petco Health & Wellness Company, Inc. (WOOF) reported that Chief Legal Officer and Secretary Giovanni Insana had 10,688 shares of Class A common stock withheld on September 4, 2026 to satisfy tax liability, valued at $2.52 per share. Following this tax-withholding disposition, he holds 386,659 shares directly, including 180,460 outstanding RSUs granted under the 2021 Equity Incentive Plan, with each RSU representing the right to receive one share of Class A common stock.
Petco Health & Wellness Company, Inc. (WOOF) reported essentially flat sales but stronger profitability for the quarter ended August 1, 2026. Net sales were $1.49 billion, up slightly year over year, with comparable sales increasing 0.6%. Services and other revenue grew, while supplies and companion animals declined, and consumables were stable.
Gross margin improved to 39.7% and operating income rose to $47.8 million, aided by a $6.8 million net tariff refund. Net income attributable to Class A and B‑1 stockholders increased to $38.7 million, and Adjusted EBITDA grew to $122.2 million, expanding margin to 8.2%. Free cash flow for the first half of fiscal 2026 was $60.8 million, supported by better working capital and tariff refunds. Petco refinanced its term loan, issued $600 million of senior secured notes maturing 2031, and ended the quarter with $293.5 million in cash and $487.6 million of ABL availability, while remaining in covenant compliance.
Petco Health & Wellness Company, Inc. (WOOF) reported second quarter 2026 net sales of $1.49 billion, up 0.05% year over year, with comparable sales up 0.6%. Results include a $6.8 million net benefit from IEEPA tariff refunds tied to 2025–2026 tariffs.
Gross profit rose to $591.1 million, expanding gross margin to 39.7%, while operating income increased to $47.8 million. Net income grew to $38.7 million from $14.0 million and Adjusted EBITDA reached $122.2 million. Year-to-date free cash flow was $60.8 million, and quarter-end cash was $293.5 million.
Total debt was $1.48 billion with net debt of $1.19 billion; subsequent to quarter-end, the company prepaid $75 million of debt, part of $170 million of prepayments over nine months, supporting its 2x leverage ratio target. Petco reaffirmed its full-year 2026 outlook for net sales (flat to up 1.5%) and Adjusted EBITDA of $415–$430 million, and guided Q3 2026 net sales growth of 0.4–1.0% and Adjusted EBITDA of $100–$103 million.
Petco Health & Wellness Company, Inc. director Jeffrey G. Naylor filed an initial insider ownership statement listing 25,000 shares of Class A Common Stock held directly. This initial statement lists only this holding and does not include any purchases or sales of Petco stock.
Petco Health and Wellness Company, Inc. reported board changes effective August 1, 2026. Director Cameron Breitner resigned from the board and its committees, with the company stating his resignation was not due to any disagreement regarding operations, policies or practices.
The board appointed Jeffrey Naylor as an independent Class I director and Chair of the Audit Committee, effective immediately after the resignation. The board determined he qualifies as independent under Nasdaq rules and Rule 10A-3 and noted he is a designee of controlling stockholder Scooby Aggregator, LP under a Stockholder’s Agreement. Naylor will enter into Petco’s standard director indemnification agreement and receive compensation under its director compensation program. A press release dated August 3, 2026 announced his appointment.